Cerebral perfusion and postoperative recovery quality
Conditions
Interventions
placebo group:Unilateral stellate ganglion block with 5 mL of 0.9% saline solution
Blank control group:none
Experimental Group:5 mL of 0.25% ropivacaine for stellate ganglion block on the side of surgery
Sponsors
Chengdu Seventh People's Hospital
Eligibility
Sex/Gender
All
Age
55 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1: Ages 55–85 2: Patients who have undergone total or partial hip replacement surgery 3: ASA I–III 4: BMI 15–30 kg/m² 5: Informed consent from the patient and family members, with the informed consent form signed
Exclusion criteria
Exclusion criteria: 1: Patients with communication difficulties due to severe dementia, cognitive impairment, speech disorders, severe hearing or visual impairment, or psychiatric disorders 2: Patients with severe systemic infections or infections, scars, or masses at the site of stellate ganglion block 3: Patients with coagulation disorders 4: Patients with preoperative Horner’s syndrome or paralysis of the phrenic or recurrent laryngeal nerves; a history of glaucoma; or limited head and neck mobility 5: Patients with severe hepatic insufficiency (Child-Pugh Class C) or renal dysfunction (requiring renal replacement therapy) 6: Patients with cardiac conduction abnormalities; those with echocardiographic evidence of systolic or diastolic dysfunction (EF < 55%); or those with severe carotid artery stenosis or occlusion 7: Patients with a history of moderate-to-severe traumatic brain injury or neurosurgical procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recognitive function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Score of QoR-15 questionnaire on the first day of postoperative recovery quality assessment;Carotid hemodynamic index;Costs during hospitalization;Duration of hospitalization; | — |
Countries
China
Contacts
Public ContactZhang Fujun
Chengdu Seventh People's Hospital
Outcome results
None listed